Kuang Li Biotech Holdings Co., Ltd.
光麗生技控股股份有限公司 romanised, not a registered English name
Leave your email for change alerts (optional)
2012Founded
NT$974MPaid-in capital
0Plants
NT$100–500MRevenue band
- Unified Business No.
- 41181265
- Industry
- Tobacco Manufacturing (1,186)
- Listing
- Listed (TWSE) (1,087) 6431
- Founded
- 2012-07-04
- Paid-in capital
- NT$ 973,988,350
- Phone
- 02-25178779
- Website
- http://www.kl-holdings.com/
- Annual revenue band
- NT$100–500M
- Growth & profitability
- Gross margin 31.5%, operating margin -42.1%, net margin -47.8% (2026-Q2 YTD)
Processes & materials 2
- Biotechnology (664) · Company nameSelf-reported
- Testing & inspection (1,056) · Assembly & inspectionSelf-reported
Similar companies 10
- PELL BIO-MED TECHNOLOGY CO., LTD. Listed (TWSE) NT$20–100M
Shared: Biotechnology, Testing & inspection - Han Kang Biotech Co. (Cayman) Listed (TWSE) NT$20–100M
Shared: Biotechnology - Chuan Yu Biotech Holdings Co., Ltd. Listed (TWSE) NT$1–5B
Shared: Biotechnology - Jung Huei Chi Tuan Co., Ltd. Listed (TWSE) NT$1–5B
Shared: Testing & inspection - TPK Holding Co., Ltd. Listed (TWSE) ≥ NT$5B
Shared: Testing & inspection - Ho Fu Yi Liao Holdings Co., Ltd. Listed (TPEx) NT$0.5–1B estimated
Shared: Testing & inspection - ANXO PHARMACEUTICAL CO., LTD. Emerging stock (TPEx) NT$0.5–1B
Shared: Biotechnology, Testing & inspection - BAOLI BIO. TECH. CO., LTD. · New Taipei City NT$100–500M estimated
Shared: Biotechnology, Testing & inspection - Shih Chi Biotechnology Co.,Ltd. · New Taipei City NT$100–500M estimated
Shared: Biotechnology, Testing & inspection - ANBOGEN THERAPEUTICS, INC. Emerging stock (TPEx) < NT$20M estimated
Shared: Biotechnology